メインコンテンツに移動
翻訳中 — お使いの言語版を準備している間、このコンテンツは英語で表示されています。
ディスカッションに戻る

How can using advanced cancer models improve treatment options for patients with different types of cancer?

Healthcare
グローバル
August 09, 2026に開始

Nature, Published online: 05 August 2026; doi:10.1038/s41586-026-10843-7 Integration of genome-scale CRISPR screening data from traditional cell lines and next-generation cancer models expands the representation of tumour subtypes and genomic alterations in The Cancer Dependency Map

ソース記事

主張を追加 分析 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 投票すべき主張 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 投稿者： admin • Aug 09, 2026
The use of advanced cancer models should be prioritized in clinical trials to improve patient outcomes.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Incorporating diverse cancer models will lead to significant advancements in treatment for rare cancer types.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Whether researchers use organoids, patient-derived xenografts, or organ-on-chip systems, cancer models must represent the full diversity of genomic subtypes within each cancer type.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Traditional 2D cell line screening has delivered most approved cancer drugs and should remain the foundation of drug discovery, with 3D models as secondary validation.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Cancer research must integrate diverse tumour subtypes and genomic alterations into predictive models, regardless of which model platform proves most effective.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Advanced cancer models will enable more personalized treatment options for patients across various cancer types.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Integrating genome-scale CRISPR data with next-generation cancer models will enhance our understanding of tumor biology.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Mandating next-generation models in drug development will delay life-saving treatments from reaching patients with rare cancers.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Patient-derived cancer models raise serious ethical concerns about tissue ownership and informed consent that must be resolved before expansion.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results
CLAIM 投稿者： admin • Aug 09, 2026
Funding for cancer research should prioritise mapping genomic dependencies across all 25+ cancer types over funding any single model technology.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
💬 ディスカッションを見る
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us